Literature DB >> 22162230

Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer.

Eric J Duell1.   

Abstract

Tobacco smoking represents an important known cause of ductal pancreatic adenocarcinoma. Recent data from pooled analyses in consortia involving multiple case-control and cohort studies suggest that heavy (but not moderate or light) alcohol consumption also may increase pancreatic cancer risk. Animal and human evidence indicate that tobacco carcinogens and metabolites may act in concert and have both genetic and epigenetic effects at early and later stages in pancreatic tumorigenesis. One of the more important tobacco-related carcinogens, NNK, probably acts via multiple pathways. Heavy alcohol consumption may increase pancreatic cancer risk by potentiating the effects of other risk factors such as tobacco smoking, poor nutrition, and inflammatory pathways related to chronic pancreatitis, but also may have independent genetic and epigenetic effects. Animal and human studies of tobacco- and alcohol-related pancreatic carcinogenesis suggest multi-modal, overlapping mechanistic pathways. Tobacco smoking and heavy alcohol consumption are preventable exposures, and their avoidance would substantially decrease the burden of pancreatic cancer worldwide.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22162230     DOI: 10.1002/mc.20786

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  49 in total

1.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

2.  Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan.

Authors:  Sawako Kuruma; Naoto Egawa; Masanao Kurata; Goro Honda; Terumi Kamisawa; Junko Ueda; Hiroshi Ishii; Makoto Ueno; Haruhisa Nakao; Mitsuru Mori; Keitaro Matsuo; Satoyo Hosono; Shinichi Ohkawa; Kenji Wakai; Kozue Nakamura; Akiko Tamakoshi; Masanori Nojima; Mami Takahashi; Kazuaki Shimada; Takeshi Nishiyama; Shogo Kikuchi; Yingsong Lin
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?

Authors:  Leticia M Nogueira; Christina C Newton; Michael Pollak; Debra T Silverman; Demetrius Albanes; Satu Männistö; Stephanie J Weinstein; Eric J Jacobs; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-17       Impact factor: 4.254

Review 4.  Familial Pancreatic Ductal Adenocarcinoma.

Authors:  Kelly E Diaz; Aimee L Lucas
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

5.  Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4).

Authors:  C Bosetti; E Lucenteforte; D T Silverman; G Petersen; P M Bracci; B T Ji; E Negri; D Li; H A Risch; S H Olson; S Gallinger; A B Miller; H B Bueno-de-Mesquita; R Talamini; J Polesel; P Ghadirian; P A Baghurst; W Zatonski; E Fontham; W R Bamlet; E A Holly; P Bertuccio; Y T Gao; M Hassan; H Yu; R C Kurtz; M Cotterchio; J Su; P Maisonneuve; E J Duell; P Boffetta; C La Vecchia
Journal:  Ann Oncol       Date:  2011-11-21       Impact factor: 32.976

6.  Elevated inflammation in association with alcohol abuse among Blacks but not Whites: results from the MIDUS biomarker study.

Authors:  Yusuf Ransome; Natalie Slopen; Oskar Karlsson; David R Williams
Journal:  J Behav Med       Date:  2017-12-11

Review 7.  Alcohol consumption on pancreatic diseases.

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Jesus Maria Bañales; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

8.  Gamma-amino butyric acid (GABA) prevents the induction of nicotinic receptor-regulated signaling by chronic ethanol in pancreatic cancer cells and normal duct epithelia.

Authors:  Mohammed H Al-Wadei; Hussein A N Al-Wadei; Hildegard M Schuller
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-04

9.  Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).

Authors:  Haonan Li; Allison L Yang; Yeon Tae Chung; Wanying Zhang; Jie Liao; Guang-Yu Yang
Journal:  Carcinogenesis       Date:  2013-05-20       Impact factor: 4.944

Review 10.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.